Information for US Customers:
Our dedicated US website is now available at us.sudoscan.com. Feel free to visit it for local product information and support.

SUDOSCAN
THERAPEUTIC AREAS
Diabetes
SUDOSCAN efficacy in early detection of diabetic neuropathy has been demonstrated in several studies.

Neurology
Small fiber neuropathies have been assessed using SUDOSCAN in different diseases and therapeutic areas.

Oncology
SUDOSCAN has demonstrated its clinical utility to detect chemotherapy induced polyneuropathy (CIPN).

Nephrology
SUDOSCAN has demonstrated its clinical utility in Nephrology.

Follow-up
A key clinical application of SUDOSCAN is longitudinal follow-up and patient management.
SCIENCE & RESEARCH
WHO WE ARE
- About Impeto Medical
- Impeto Medical in the World

NEWS & EVENTS

NEWS & EVENTS

NEWS & EVENTSSebastien2025-01-15T14:04:02+00:00

Events
Sudoscan participates to the 29th edition of the SFNP 2025
Sudoscan participates to the 29th edition of the SFNP 2025
January 15, 2025

Events

SUDOSCAN at NEURODIAB 2021
SUDOSCAN at NEURODIAB 2021: Symposium and five oral communications Impeto [...]

Read Article

Events

Successful Webinar “Management of autonomic dysfunction” – July 2021
Successful Webinar: Management of autonomic dysfunction: challenges & role of [...]

Read Article

Events

Successful Webinar “Early management of diabetes & microvascular complications” – April 2021
Successful Webinar: Early Management of diabetes & microvascular complications. With our [...]

Read Article

Infectious disease / News / Scientific publications

SUDOSCAN and COVID-19
Sudomotor dysfunction in patients recovered from COVID-19 Anand Hinduja, Abdul [...]

Read Article

Subscribe to receive our scientific news

Email(Required)

Name(Required)

Diabetes,Events
SUDOSCAN at the EASD Annual Meeting 2022
March 10, 2026

Events
SUDOSCAN at the 5th JNC Congress 2022
March 10, 2026

Events
SUDOSCAN at the EAN Congress 2022
March 10, 2026

About Sudoscan

Sudoscan is a class IIa Medical device, Manufactured by Impeto Medical, indicated for early identification and follow-up of peripheral autonomic neuropathies.

For professional use only, read instructions before use. This medical device is a regulated health product which bears, under this regulation, the CE mark

Sudoscan in the world

More information

Sudoscan Technology

Contact info

France HEADQUARTERS: 2 rue Maurice Hartmann, 92130 Issy Les Moulineaux
Phone: +33 (0)7 87 20 32 03

Sudoscan USA: 8525 Gibbs Dr Suite 304, San Diego, CA 92123, États-Unis
Phone: 858-450-2800

Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12